We have observed
3 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after August 21, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
Synthetic artificial peptides having an anti-microbial effect
INFLUENZA VIRUS BINDING PEPTIDES
METHOD FOR DETERMINING A MUTATION IN GENOMIC DNA, USE OF THE METHOD AND KIT FOR CARRYING OUT SAID METHOD